Moreover, considering that CCND1 plays essential roles in current therapeutic strategies for ovarian cancer patients that involve platinum therapy and checkpoint inhibitors, the exploration of the functions of PSMC2 and CCND1 in ovarian cancer should be of great significance. This evidence concerns the gene CCND1 and ovarian carcinoma.